NYSE:VARVarian Medical Systems Stock Price, Forecast & News

Varian Medical Systems' stock was trading at $113.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, VAR shares have increased by 5.5% and is now trading at $119.25. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 2 sell ratings, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Varian Medical Systems.

Varian Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Varian Medical Systems.

Varian Medical Systems, Inc. (NYSE:VAR) announced its quarterly earnings results on Monday, May, 4th. The medical equipment provider reported $0.85 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.85. The medical equipment provider earned $794.50 million during the quarter, compared to analyst estimates of $769.99 million. Varian Medical Systems had a net margin of 7.51% and a return on equity of 22.93%. The company's revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.05 earnings per share. View Varian Medical Systems' earnings history.

8 brokers have issued twelve-month price targets for Varian Medical Systems' stock. Their forecasts range from $90.00 to $150.00. On average, they expect Varian Medical Systems' share price to reach $125.25 in the next twelve months. This suggests a possible upside of 5.0% from the stock's current price. View analysts' price targets for Varian Medical Systems.

News coverage about VAR stock has trended very negative recently, according to InfoTrie. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Varian Medical Systems earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Varian Medical Systems.

Varian Medical Systems saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 3,650,000 shares, an increase of 11.6% from the June 15th total of 3,270,000 shares. Based on an average daily volume of 809,300 shares, the short-interest ratio is presently 4.5 days. Approximately 4.0% of the shares of the company are sold short. View Varian Medical Systems' Current Options Chain.

Some companies that are related to Varian Medical Systems include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Insulet (PODD) and Steris (STE). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T), Thermo Fisher Scientific (TMO), Visa (V), Align Technology (ALGN), Intel (INTC), Pfizer (PFE) and Verizon Communications (VZ).

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Varian Medical Systems' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.09%), JLB & Associates Inc. (0.08%), State of Alaska Department of Revenue (0.06%), DNB Asset Management AS (0.02%), Rockland Trust Co. (0.01%) and IFM Investors Pty Ltd (0.01%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View institutional ownership trends for Varian Medical Systems.

VAR stock was sold by a variety of institutional investors in the last quarter, including IFM Investors Pty Ltd, Thomasville National Bank, and Nelson Van Denburg & Campbell Wealth Management Group LLC. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert, and Timothy E Guertin. View insider buying and selling activity for Varian Medical Systems.

VAR stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Canandaigua National Corp, Everence Capital Management Inc., Carnegie Capital Asset Management LLC, Cypress Capital Group, DNB Asset Management AS, Envestnet Asset Management Inc., and Mount Yale Investment Advisors LLC. View insider buying and selling activity for Varian Medical Systems.

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VAR stock can currently be purchased for approximately $119.25.

Varian Medical Systems has a market capitalization of $10.83 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.

The official website for Varian Medical Systems is www.varian.com.

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]